Announced
Completed
Synopsis
Sanofi, an innovative therapeutic solutions provider, completed a $180m investment in Owkin, a machine learning provider. "Owkin’s unique methodology, which applies AI on patient data from partnerships with multiple academic medical centers, supports our ambition to leverage data in innovative ways in R&D. We are striving to advance precision medicine to the next level and to discover innovative treatment methods with the greatest benefits for patients," Arnaud Robert, Sanofi Executive Vice Presidenta and Chief Digital Officer.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.